Namir joined Saba IP in 2012 and currently heads the patent department at the Head Office. Namir works alongside a team of technical experts with various technical backgrounds and provides technical and legal support across to all Saba IP branch offices. Namir and his team manage several key patent portfolios from pre-filing recommendations and strategy through prosecution and grant. Namir attends IP conferences on a regular basis and has presented on a number of those such as AIPLA, BIO and GPCA. Namir is the author on a number of patent-related articles on the MENA region published on blogs, the firm website, MIP, and The Patent Lawyer.
Before joining Saba IP, Namir worked in the pharmaceuticals industry. He occupied various roles of increasing responsibility in R&D and later on the corporate side as Alliance Manager where he managed portfolios with Genzyme (now Sanofi), Eli Lilly, Abbott and others. During his tenure at Ionis Pharmaceuticals in San Diego, CA, he co-authored several articles published in peer-reviewed scientific journals, and was a co-inventor on several patents. His technical background includes pharmaceuticals, RNAs, protein binding, PK/PD and various therapeutic areas including cardiovascular, oncology, inflammatory and neurodegenerative, as well as rare diseases.
Namir holds an undergraduate degree in biochemistry from the University of California, Los Angeles, a graduate degree in chemistry from the University of California, Santa Barbara, and an executive MBA from the American University of Beirut. Namir is a member of FICPI and APPIMAF.